Acquisition completion

RNS Number : 7757L

Croda International PLC

31 December 2018

 

Croda International Plc ("Croda")

Acquisition of leading global vaccine adjuvant specialist

Further to the announcement on 17 December 2018, Croda has now completed the acquisition of Brenntag Biosector A/S ('Biosector') from Brenntag Nordic A/S on 28 December 2018.  Biosector is a specialist in the manufacture and supply of adjuvants serving both the human and veterinary vaccine markets.  

-ENDS-

For enquiries contact:

Investors:	Conleth Campbell, VP Investor Relations, Croda	[phone]
Press:	Charlie Armitstead, Teneo	[phone]

 

END

 

 

ACQFKKDQDBDBDBN